Synergy Pharma (NASDAQ: SGYP)
| Last Price | $2.91 |
| Net Change | $0.01 (0.34%) |
| Bid | $2.88 |
| Ask Price | $2.98 |
| Open Price | $2.9 |
| Previous Close Price | $2.9 |
| High Price | $3.01 |
| Low Price | $2.89 |
| Number of Trades | 10,024 |
| Volume | 3,905,800 |
| Fifty Two Week High | $7.15 (2017-01-31) |
| Fifty Two Week Low | $2.85 (2017-08-15) |
| Average Daily Volume | 5,669,292 |
| Share Outstanding | 224,960 Shares |
| Total Dividend Payout | 0/yr |
| Dividend Yield | 0% |
| 1st Quarter Earnings | $-0.33 (2017-08-09) |
| 2nd Quarter Earnings | $ () |
| 3nd Quarter Earnings | $ () |
| 4th Quarter Earnings | $ () |
| PE Ratio | $0 |
| EPS Growth | $29.48 |
| Recent Earnings | $-0.33 |
| Annual EPS | $-1.16 |
| Last Quarter EPS | $ |
| Market Capitalization | $0.65B |
| Insider Shareholders % | 0.038% |
| Annual Revenue | $0B |
| No. Shares Outstanding | 224,960 |
| Inst. Shareholder % | 67.56% |
| Annual Net Income | $-0.24B |
| TTM Net Profit Margin | $-9900.42 |
| 1-Year Return | -43.5% |
| 3-Year Return | -19.61% |
| 5-Year Return | -38.48% |
| 5-Year Revenue Growth | 0% |
| 5-Year Earnings Growth | 303.33% |
| 5-Year Dividend Growth | 0% |
| Annual Dividend | $0 |
| Annual Dividend Yield | 0% |
| Change in EPS YTD | 29.48% |
| Dividends per Share | $ |
| Stock Split Ratio | 1-2 |
| Beta | 1047.94 |